NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MygeA.20115.a: UDP-galactopyranose mutase (MG_137)

Target Characteristics

from organism: Mycoplasma genitalium ATCC 33530 / G-37 / NCTC 10195
most recent status: target approved
center reference id: MygeA.20115.a
is community request: False
associated disease:
NIH risk group: unclassified
is select agent: False
NIH priority
pathogens category:
C

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Molecular models

Method Results
comparative modelling Robetta_10480

External Resources

Resource Reference ID
PATRIC ID: fig|243273.25.peg.149
UniProt: Q49398

Enzyme & Pathway Information

Pathway Pathway ID EC Number
O-antigen building blocks biosynthesis (E. coli) OANTIGEN-PWY 5.4.99.9
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis PWY-6397 5.4.99.9
superpathway of mycolyl-arabinogalactan-peptidoglycan complex biosynthesis PWY-6404 5.4.99.9
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis PWY-7328 5.4.99.9
UDP-alpha-D-galactofuranose biosynthesis PWY-7622 5.4.99.9

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MNVILSVMLF SSPSCVNINS FDILIVGAGI SGIVLANILA NHNKRVLIVE KRDHIGGNCY DKVDSKTQLL FHQYGPHIFH TNNQTVINFI SPFFELNNYH HRVGLKLKNN LDLTLPFDFQ QIYKLMGKDG RKLVSFFKEN FSLNTHLSLA ELQLIDNPLA QKLYQFLISN VYKPYSVKMW GLPFAMINEN VINRVKIVLS EQSSYFPDAI IQGLPKSGYT NSFLKMLANP LIDVQLNCKD NLLVYQDEKL FFNNNLIEKP VVYCGLIDKL FNFCFGHLQY RSLAFSWKRF NQKKYQTYPV VNMPLAKSIT RSVEYKQLTN QGSFKPQTIV SFETPGSYAI NDPRFNEPYY PINNTLNDTL FKKYWKKASK LKNLHLLGRL ATYQYIDMDK AILLSIKKAQ QLLS

NT Sequence
GTGAATGTAA TTCTATCCGT GATGTTGTTT TCTTCCCCCA GTTGCGTGAA CATAAATAGT TTTGATATTT TAATTGTTGG TGCTGGTATT AGTGGAATAG TACTAGCTAA CATCTTAGCT AATCACAATA AAAGGGTTTT AATTGTTGAA AAAAGAGATC ATATTGGTGG TAACTGTTAT GATAAAGTTG ATAGTAAAAC TCAACTCTTG TTTCACCAGT ATGGACCCCA TATTTTCCAT ACTAACAACC AAACTGTTAT TAACTTTATC TCACCCTTCT TTGAACTAAA TAACTACCAC CATCGGGTTG GTTTAAAATT GAAAAATAAC CTAGATTTAA CCTTACCCTT TGATTTTCAA CAGATCTATA AACTAATGGG AAAAGATGGT AGAAAACTCG TTAGTTTTTT TAAAGAAAAT TTCAGTTTAA ATACTCATCT ATCATTAGCA GAATTACAAC TAATTGATAA TCCTTTAGCA CAAAAACTCT ATCAGTTTTT AATTAGTAAT GTTTATAAAC CATACAGTGT CAAAATGTGG GGTTTACCAT TTGCAATGAT TAATGAGAAT GTTATTAACA GGGTCAAGAT AGTTTTAAGT GAACAAAGCA GTTATTTTCC TGATGCAATT ATCCAGGGAT TACCTAAATC AGGTTATACA AACAGTTTTC TTAAGATGTT AGCCAATCCC TTAATTGATG TGCAGTTAAA CTGCAAAGAT AACCTTTTAG TTTATCAAGA TGAAAAACTG TTTTTTAACA ATAACTTAAT AGAAAAACCA GTTGTTTACT GTGGCTTAAT TGACAAGCTA TTTAACTTTT GCTTTGGTCA TTTGCAATAC CGTTCTCTTG CCTTTAGTTG AAAAAGATTT AACCAAAAAA AATACCAAAC CTACCCTGTT GTTAATATGC CTTTAGCTAA ATCAATCACA AGGAGTGTGG AATACAAACA ACTAACAAAC CAAGGTTCTT TCAAACCGCA AACCATCGTT AGTTTTGAAA CCCCTGGCAG CTATGCAATT AACGATCCTA GGTTTAATGA ACCTTATTAC CCAATTAACA ATACACTAAA TGATACTCTT TTTAAAAAGT ACTGAAAAAA AGCAAGTAAG TTAAAGAATC TACACCTTTT GGGAAGATTA GCAACCTACC AATACATTGA TATGGATAAA GCAATCCTAC TTAGTATTAA AAAAGCCCAA CAACTGTTAA GT

© 2020 Seattle Children's Research Institute. All rights reserved.